VANCOUVER, BRITISH COLUMBIA--(Marketwire - March 17, 2008) - Dragon Pharmaceutical Inc. (“Dragon” or the “Company”) (TSX:DDD)(OTCBB:DRUG)(BBSE:DRP), a leading international pharmaceutical company, today announced it has retained cQuest, a capital markets advisory affiliate of Christensen, to facilitate and execute its investor and media relations campaigns. cQuest specializes in assisting companies with market capitalizations of less than $200 million to achieve fair market valuation and strengthen brand recognition in the global financial markets and financial media. Retaining cQuest reinforces Dragon’s commitment to maximizing shareholder value by improving external communications and increasing visibility within the financial community.
